Dr. Tony Gianduzzo provides high quality prostate cancer diagnostics supported by world-class prostate MRI, PSMA PET and uropathology services, underwritten by Dr. Tony's 23 years of clinical experience.

Sunshine Coast Urology is proud to be able to offer the latest in prostate cancer diagnostics.

• Prostatic mpMRI - a new way to accurately image the prostate to better identify potential significant prostate cancers.  This is provided locally in conjunction with world-recognised Wesley Medical Imaging.
• Robotically targeted transperineal prostatic biopsy - a new way to biopsy the prostate and provide an optimised diagnostic pathway with more accurate diagnosis.             The Mona Lisa BioBot provides unsurpassed accuracy during biopsy of MRI identified prostatic lesions, allowing precise control of each biopsy core. Biopsies are taken through only two two transperineal puncture sites, dramatically reducing the incidence of infective complications compared to classical transrectal biopsy.
• Revised Uropathology - a better way of assessment of the likely behaviour of a prostate cancer from its microscopic appearance. Services are provided by internationally recognised prostate cancer expert, Professor Hema Samaratunga.
• PSMA scanning - a new way to detect early cancer spread, and so better decide appropriate treatment. This exacting technology is now available locally in conjunction with Wesley Medical Imaging.

It is vital that patients understand what is happening and why. In each step of the process of evaluation for possible prostate cancer there is advice and shared decision-making.    Dr. Tony first assesses patient’s clinical history, examination, and pathology results. Some patients can be reassured or observed. Other may benefit from a mpMRI and/or biopsy of the prostate. Patients who are then found to have prostate cancer are then further checked for possible spread.

Much can be done for those who are unfortunate enough to have prostate cancer found. The nature of prostate cancer varies greatly, and treatment recommendations are individualised for the patient. For some, careful ongoing observation may be enough. Others may require active treatment of their cancer. This may mean referral on for surgery (radical prostatectomy) in a high-volume centre of excellence, or radiotherapy.